from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0113/gmhA

LFCtreatmentdescriptionclass of inhibitor

0.193

Amikacinug/mL Amikacintranslation

0.574

Cap5-10ug/mL Capreomycintranslation

0.124

Rox10-50 ug/mL Roxithromycintranslation

-0.641

SM2-5 ug/mL Streptomycintranslation

0.118

Tet5-10 ug/mL Tetracyclinetranslation

-0.165

Rif0.2-5ug/mL Rifampicintranscription

0.485

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.686

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.042

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.193

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.014

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.420

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.517

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.944

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.818

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.404

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.112

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.671

Nigericin50 uM Nigericinrespiration

0.190

TRC10-150 ug/mL Triclosanrespiration

1.352

TRZ10-25 ug/mL Thioridazinerespiration

0.360

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.120

menadione6-10 ug/mL Menadionerespiration

0.587

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.005

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.714

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.657

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.206

NRP_1Non-replicating persistence stage 1dosRassociated

-1.037

Amp0.2mg/mL AmpicillincellWall

0.714

Cephalexin20-100 ug/mL CephalexincellWall

0.179

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.364

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.884

EMB10-20 ug/mL EthambutolcellWall

-0.531

Eta12-40 ug/mL EthionamidecellWall

-0.548

INH0.2-0.4 ug/mL IsoniazidcellWall

0.075

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.759

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.126

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.922

BZA0.12 mg/mL BenzamidearomaticAmides

-1.018

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.007

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.334

H2O24 mM hydrogen peroxideDNAdamaging

0.539

Levo10 ug/mL LevofloxacinDNAdamaging

-0.241

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.543

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.133

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.287

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.351

Antimycin12.5-50 ug/mL Antimycin A?

0.300

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.439

PA_110-50 ug/mL Antitubercular compound PA-1?

0.463

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.268

PA8240.2-2 ug/mL PA-824?

-0.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.252

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.011

Verapamil50 uM Verapamil?

-0.453

mercaptoethanol2 mM 2-Mercaptoethanol?

0.611

methoxatin10-20 ug/mL Methoxatin?